Get started
Work

Tu1301 Validation of a Homogenous Mobility Shift Assay (HMSA) for the Measurement of Vedolizumab (VLM) and Anti-VLM Antibodies in Inflammatory Bowel Disease (IBD) Patient Serum

Year: 2015
Type: conference-abstract
DOI: 10.1016/s0016-5085(15)32889-4
Authors: Jared Salbato, Stefan Westin, Rukmini Reddy, Nisha Donthi, Anjali Jain, Sharat Singh
Language: English
Subfield: Genetics
Open Access status: bronze
OpenAlex ID: W2317201234
Cites:
Cited by:
Related to: 10